ST
RDY icon

Smithfield Trust’s Dr. Reddy's Laboratories RDY Stock Holding History

Smithfield Trust’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,260
Closed -$56K – 810
2016
Q4 		$56K Sell
6,260
-425
-6% -$3.96K 0.01% 503
2016
Q3 		$62K Buy
+6,685
New +$63.8K 0.01% 477
2014
Q2 		– Sell
-12,155
Closed -$106K – 841
2014
Q1 		$106K Sell
12,155
-960
-7% -$8.35K 0.02% 435
2013
Q4 		$108K Sell
13,115
-925
-7% -$7.32K 0.02% 424
2013
Q3 		$106K Buy
14,040
+3,450
+33% +$25.1K 0.02% 410
2013
Q2 		$80K Buy
+10,590
New +$77.3K 0.02% 428

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Smithfield Trust's RDY Position: Q1 2017 in Review

Smithfield Trust sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 6,260 shares — an estimated $56K sold.

Smithfield Trust first reported a position in RDY in Q2 2013 and held it in 6 quarters. The position peaked at $108K in Q4 2013. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

  • Smithfield Trust reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
  • Smithfield Trust sold 6,260 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $56K.
  • Smithfield Trust first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 6 quarters.
  • Smithfield Trust's Dr. Reddy's Laboratories position peaked at $108K in Q4 2013.
  • 134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on Smithfield Trust's 13F filing for Q1 2017, filed 1 May 2017.